Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about Parkinsonâs Disease Recent news which mentions Parkinson’s Disease Edward L. Weidenfeld, Reagan Attorney & DC Socialite Who Went From Capitol Hill To Cannabis Entrepreneur Dies At 79 January 10, 2023 Tags Edward L/ Weidenfeld News Andras Kirschner From Benzinga PharmaTher Presents Positive Data On Ketamine For Treatment Of Dyskinesia In Parkinson's Disease September 17, 2022 Tickers PHRRF Tags News PharmaTher Holdings Fabio Chianelli From Benzinga AbbVie Walks Away From Parkinson's Drug Pact With BioArctic April 20, 2022 Tickers ABBV Tags Benzinga Market News Parkinson’s Disease From Benzinga Gain Therapeutics Shares Skyrocket After Preclinical Data From Parkinson's Program April 12, 2022 Tickers GANX Tags Parkinson’s Disease Market News Benzinga From Benzinga Prothena Highlinghts New Preclinical Data For Alzheimer's, Parkinson's Vaccine Programs March 16, 2022 Tickers PRTA Tags General Briefs News From Benzinga Gain Therapeutics Posts Encouraging Preclinical Data From Parkinson's, Alzheimer's Programs March 15, 2022 Tickers GANX Tags Alzheimer's disease Biotech Preclinical Phase From Benzinga 4D Pharma To Test Its Single-Strain Live Biotherapeutics In Parkinson's Disease February 22, 2022 Tickers LBPS Tags General News Briefs From Benzinga FDA Guides Annovis Bio For Two Phase 3 Buntanetap Trial In Parkinson's Disease January 25, 2022 Tickers ANVS Tags Phase 3 Trial Health Care General From Benzinga Yumanity Shares Fall On FDA Hold On Multidose Trials In Parkinson's Disease January 19, 2022 Tickers YMTX Tags Biotech YMTX Health Care From Benzinga Yumanity Therapeutics Stock Plunges After Parkinson's Trial Data November 10, 2021 Tickers YMTX Tags Movers Briefs News From Benzinga Why Did BioVie Shares Jump 21% Today? October 26, 2021 Tickers BIVI Tags Trading Ideas Benzinga Market News From Benzinga EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo October 05, 2021 Tickers ANVS Tags Exclusives General Briefs From Benzinga Inhibikase Shares Interim 3-Month Toxicology Studies Data Of Parkinson's Candidate October 04, 2021 Tickers IKT Tags General Movers Briefs From Benzinga Stealth Bio Posts Encouraging Preclinical Data In Parkinson's Animal Studies September 23, 2021 Tickers MITO Tags Market News Parkinson’s Disease Penny Stocks From Benzinga Gain Therapeutics' Gaucher, Parkinson's Candidate Shows Potential In Patient-Derived iPSC Study September 08, 2021 Tickers GANX Tags Movers News Briefs From Benzinga Amneal's Parkinson's Candidate Shows Efficacy In Pivotal Trial August 26, 2021 Tickers AMRX Tags Small Cap Biotech Health Care From Benzinga AbbVie, Mission Therapeutics Pick Alzheimer's & Parkinson's Targets In Neurodegenerative Disease Collaboration August 09, 2021 Tickers ABBV Tags Biotech News Contracts From Benzinga Clene's Stock Gain As Its Nanotherapeutic Improves Energy Production, Brain Utilization In Patients With Parkinson's, Multiple Sclerosis August 05, 2021 Tickers CLNN Tags Small Cap Biotech CLNN From Benzinga IBM, Michael J. Fox Foundation Using Artificial Intelligence To Fight Parkinson's Disease July 29, 2021 Tickers IBM TECH Tags General News artificial intelligence From Benzinga AC Immune Secures Funding From BioNTech Investors, Buys Parkinson's Vaccine Candidate July 27, 2021 Tickers ACIU BNTX Tags Biotech Small Cap Health Care From Benzinga Inhibikase To Start Testing Its Parkinson's Candidate In Patients July 26, 2021 Tickers IKT Tags Briefs News Biotech From Benzinga Acorda Therapeutics Shares Gains On Spain Distribution Pact For Parkinson's Med July 23, 2021 Tickers ACOR Tags News Briefs Movers From Benzinga Ipsen In-Licenses Parkinson's Candidate From IRLAB July 15, 2021 Tickers IPSEY Tags Parkinson’s Disease Market News Benzinga From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.